Literature DB >> 5314166

Transport characteristics of folates in cerebrospinal fluid; a study utilizing doubly labeled 5-methyltetrahydrofolate and 5-formyltetrahydrofolate.

M Levitt, P F Nixon, J H Pincus, J R Bertino.   

Abstract

Serum disappearance curves in dogs after the intravenous injection of radioactive methotrexate, 5-methyltetrahydrofolate, 5-formyltetrahydrofolate, and folic acid followed first-order kinetics with half-disappearance times ranging from 1.3 to 9 hr respectively. Equilibration of spinal fluid tritium levels with those in serum was rapid (3.0 hr) for both of the reduced folates but was not observed at any time after folic acid and methotrexate. The only radioactive folate identified in the spinal fluid after intravenous injection of either 5-formyltetrahydrofolate or folic acid, as well as 5-methyltetrahydrofolate was 5-methyltetrahydrofolate. These findings indicated that 5-methyltetrahydrofolate was taken up preferentially into the spinal fluid and that the other folate congeners were converted to this compound before uptake. Diphenylhydantoin administration did not alter the uptake of 5-methyltetrahydrofolate into the spinal fluid but was associated with reduced renal excretion of this compound.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5314166      PMCID: PMC292061          DOI: 10.1172/JCI106609

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  METHOTREXATE DISPLACEMENT IN MAN.

Authors:  D G JOHNS; J W HOLLINGSWORTH; A R CASHMORE; I H PLENDERLEITH; J R BERTINO
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

2.  Cerebrospinal fluid iodide.

Authors:  B BECKER
Journal:  Am J Physiol       Date:  1961-12

3.  Studies on the identification of a folate compound of human serum.

Authors:  V HERBERT; A R LARRABEE; J M BUCHANAN
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

4.  Megaloblastic anemia and mental retardation associated with hyperfolic-acidemia: probably due to N5 methyltetrahydrofolate transferase deficiency.

Authors:  T Arakawa; K Narisawa; K Tanno; Y Hirooka; T Ono
Journal:  Tohoku J Exp Med       Date:  1967-09       Impact factor: 1.848

5.  Transport of methotrexate by the choroid plexus.

Authors:  R Rubin; E Owens; D Rall
Journal:  Cancer Res       Date:  1968-04       Impact factor: 12.701

6.  Brain folate concentration in folate-deficient rats receiving diphenylhydantoin.

Authors:  C D Allen; F A Klipstein
Journal:  Neurology       Date:  1970-04       Impact factor: 9.910

7.  Purines: active transport by isolated choroid plexus.

Authors:  R D Berlin
Journal:  Science       Date:  1969-03-14       Impact factor: 47.728

8.  Logarithmic-normal distribution of cerebrospinal fluid folate concentrations.

Authors:  N Weckman; R Lehtovaara
Journal:  Experientia       Date:  1969-06-15

9.  Isolated defect of folic acid absorption associated with mental retardation and cerebral calcification.

Authors:  P Lanzkowsky; M E Erlandson; A I Bezan
Journal:  Blood       Date:  1969-10       Impact factor: 22.113

10.  Lactobacillus casei C.S.F. folate activity.

Authors:  D G Wells; H J Casey
Journal:  Br Med J       Date:  1967-09-30
View more
  18 in total

1.  CSF 5-Methyltetrahydrofolate Serial Monitoring to Guide Treatment of Congenital Folate Malabsorption Due to Proton-Coupled Folate Transporter (PCFT) Deficiency.

Authors:  A Torres; S A Newton; B Crompton; A Borzutzky; E J Neufeld; L Notarangelo; G T Berry
Journal:  JIMD Rep       Date:  2015-05-26

Review 2.  The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption.

Authors:  Rongbao Zhao; Srinivas Aluri; I David Goldman
Journal:  Mol Aspects Med       Date:  2016-09-21

3.  Folic acid deficiency and epilepsy.

Authors:  J W Norris; R F Pratt
Journal:  Drugs       Date:  1974       Impact factor: 9.546

4.  Diffusion and flow transfer of theophylline across the blood-brain barrier: pharmacokinetic analysis.

Authors:  M D Karol; P Veng-Pedersen; R E Brashear
Journal:  J Pharmacokinet Biopharm       Date:  1983-06

Review 5.  Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.

Authors:  Rongbao Zhao; Larry H Matherly; I David Goldman
Journal:  Expert Rev Mol Med       Date:  2009-01-28       Impact factor: 5.600

Review 6.  Drugs and folate metabolism.

Authors:  D G Lambie; R H Johnson
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

7.  The inability of oral leucovorin to elevate CSF 5-methyl-tetrahydrofolate following high dose intravenous methotrexate therapy.

Authors:  J Allen; G Rosen; H Juergens; B Mehta
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

8.  Phase I clinical trial and pharmacology of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (metoprine) (DDMP) and folinic acid (CF).

Authors:  R de Jager; D Dupont; J J Rodzynek; C Dorlet; G Lagrange
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

9.  Partial purification and characterization of a folate-binding protein from human choroid plexus.

Authors:  S A Suleiman; R Spector; P Cancilla
Journal:  Neurochem Res       Date:  1981-03       Impact factor: 3.996

Review 10.  Pteridines and mono-amines: relevance to neurological damage.

Authors:  I Smith; D W Howells; K Hyland
Journal:  Postgrad Med J       Date:  1986-02       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.